Synthesis of methotrexate-conjugated gold nanoparticles with enhanced cancer therapeutic effect

Biochemical Engineering Journal

Volumn 78, Issue , 2013, Pages 175-180

  Tran, Ngoc Thi Thanh ^a   Wang, Tzu Hao ^b   Lin, Chiao Yun ^b   Tai, Yian ^a  

^a NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cancer therapy; Gold nanoparticles; In vitro; Methotrexate

Indexed keywords

CANCER THERAPY; CHEMICAL INTERACTIONS; FOURIER TRANSFORM INFRA REDS; GOLD NANOPARTICLES; IN-VITRO; LACTATE DEHYDROGENASE; METHOTREXATE; UV-VIS SPECTROSCOPY;

CELL CULTURE; CYTOTOXICITY; DISEASES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GOLD; METAL NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET VISIBLE SPECTROSCOPY; X RAY DIFFRACTION;

SYNTHESIS (CHEMICAL);

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GOLD NANOPARTICLE; LACTATE DEHYDROGENASE; METHOTREXATE;

ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CHEMICAL INTERACTION; CHORIOCARCINOMA; CYTOTOXICITY; HUMAN; HUMAN CELL; INFRARED SPECTROMETRY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; THERAPY EFFECT; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET RADIATION; X RAY DIFFRACTION;

EID: 84882590963     PISSN: 1369703X     EISSN: 1873295X     Source Type: Journal    
DOI: 10.1016/j.bej.2013.04.017     Document Type: Article

References (35)

1. Twombly R. Cancer surpasses heart disease as leading cause of death for all but the very elderly. J. Natl. Cancer Inst. 2005, 97:330-331.
2. Jeong H.J., Lee J.R., Jeong J.B., Park J.H., Cheong Y.K., De Lumen B.O. The cancer preventive seed peptide lunasin from rye is bioavailable and bioactive. Nutr. Cancer 2009, 61:680-686.
3. Kang S., Chen J. Targeting RSK2 in human malignancies. Expert Opin. Ther. Targets 2011, 15:11-20.
4. Suzuki N., Liu X., Laxmi Y.R.S., Okamoto K., Kim H.J., Zhang G., Chen J.J., Okamoto Y., Shibutani S. Anti-breast cancer potential of SS5020, a novel benzopyran antiestrogen. Int. J. Cancer 2011, 128:974-982.
5. Hung C.T., McLeod A.D., Gupta P.K. Formulation and characterization of magnetic polyglutaraldehyde nanoparticles as carriers for poly-l-lysine-methotrexate. Drug Dev. Ind. Pharm. 1990, 16:509-521.
6. Narayani R., Panduranga Rao K. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres. J. Microencapsulation 1994, 11:69-77.
7. Wosikowski K., Biedermann E., Rattel B., Breiter N., Jank P., Löser R., Jansen G., Peters G.J. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin. Cancer Res. 2003, 9:1917-1926.
8. Arias J.L. Drug targeting strategies in cancer treatment: an overview. Mini Rev. Med. Chem. 2011, 11:1-17.
9. Zhang H., Chen B., Jiang H., Wang C., Wang H., Wang X. A strategy for ZnO nanorod mediated multi-mode cancer treatment. Biomaterials 2011, 32:1906-1914.
10. Morris K., Weston H., Mollee P., Marlton P., Gill D., Kennedy G. Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population. Leuk. Lymphoma 2011, 52:85-91.
11. Vermorken J.B., Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann. Oncol. 2010, 21:vii252-vii261.
12. Amadori D., Silvestrini R., De Lena M., Boccardo F., Rocca A., Scarpi E., Schittulli F., Brandi M., Maltoni R., Serra P., Ponzone R., Biglia N., Gianni L., Tienghi A., Valerio M.R., Bonginelli P., Amaducci L., Faedi M., Baldini E., Paradiso A. Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. Breast Cancer Res. Treat. 2011, 125:775-784.
13. Kamen B. Folate and antifolate pharmacology. Semin. Oncol. 1997, 24. S18-30-S18-39.
14. Vezmar S., Becker A., Bode U., Jaehde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003, 49:92-104.
15. Islam M.T., Majoros I.J., Baker J.R. HPLC analysis of PAMAM dendrimer based multifunctional devices. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 822:21-26.
16. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., Baker J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65:5317-5324.
17. Kohler N., Sun C., Fichtenholtz A., Gunn J., Fang C., Zhang M. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2006, 2:785-792.
18. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 2008, 60:1307-1315.
19. Sandhu K.K., McIntosh C.M., Simard J.M., Smith S.W., Rotello V.M. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjugate Chem. 2002, 13:3-6.
20. Hong R., Han G., Fernández J.M., Kim B.J., Forbes N.S., Rotello V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 2006, 128:1078-1079.
21. Derfus A.M., Von Maltzahn G., Harris T.J., Duza T., Vecchio K.S., Ruoslahti E., Bhatia S.N. Remotely triggered release from magnetic nanoparticles. Adv. Mater. 2007, 19:3932-3936.
22. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
23. Daniel M.C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104:293-346.
24. Dos Santos D.S., Alvarez-Puebla R.A., Oliveira O.N., Aroca R.F. Controlling the size and shape of gold nanoparticles in fulvic acid colloidal solutions and their optical characterization using SERS. J. Mater. Chem. 2005, 15:3045-3049.
25. Murphy C.J., Sau T.K., Gole A.M., Orendorff C.J., Gao J., Gou L., Hunyadi S.E., Li T. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J. Phys. Chem. B 2005, 109:13857-13870.
26. Palui G., Ray S., Banerjee A. Synthesis of multiple shaped gold nanoparticles using wet chemical method by different dendritic peptides at room temperature. J. Mater. Chem. 2009, 19:3457-3468.
27. Tran T.T.N., Wang T.H., Lin C.Y., Tsai Y.C., Lai C.H., Tai Y., Yung B. Direct synthesis of Rev peptide-conjugated gold nanoparticles and their application in cancer therapeutics. Bioconjugate Chem. 2011, 22:1394-1401.
28. Millstone J.E., Wei W., Jones M.R., Yoo H., Mirkin C.A. Iodide ions control seed-mediated growth of anisotropic gold nanoparticles. Nano Lett. 2008, 8:2526-2529.
29. Kawamura G., Yang Y., Fukuda K., Nogami M. Shape control synthesis of multi-branched gold nanoparticles. Mater. Chem. Phys. 2009, 115:229-234.
30. Sharma J., Tai Y., Imae T. Biomodulation approach for gold nanoparticles: synthesis of anisotropic to luminescent particles. Chem. Asian J. 2010, 5:70-73.
31. Mccreery R.L. Raman Spectroscopy for Chemical Analysis 2000, A John Wiley & Sons, Inc., Canada.
32. Lee S.J., Morrill A.R., Moskovits M. Hot spots in silver nanowire bundles for surface-enhanced Raman spectroscopy. J. Am. Chem. Soc. 2006, 128:2200-2201.
33. Ayyappan S., Sundaraganesan N., Aroulmoji V., Murano E., Sebastian S. Molecular structure, vibrational spectra and DFT molecular orbital calculations (TD-DFT and NMR) of the antiproliferative drug methotrexate. Spectrochim. Acta A 2010, 77:264-275.
34. Slocik J.M., Stone M.O., Naik R.R. Synthesis of gold nanoparticles using multifunctional peptides. Small 2005, 1:1048-1052.
35. Chen Y.H., Tsai C.Y., Huang P.Y., Chang M.Y., Cheng P.C., Chou C.H., Chen D.H., Wang C.R., Shiau A.L., Wu C.L. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol. Pharm. 2007, 4:713-722.